Schroder Investment Management Group’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Schroder Investment Management Group’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-1	Closed	-$2.8K	–	1504
2014 Q3	$2.8K	Hold	1	–	–	﹤0.01%	1411
2014 Q2	$3.05K	Hold	1	–	–	﹤0.01%	1364
2014 Q1	$3.23K	Hold	1	–	–	﹤0.01%	1407
2013 Q4	$2.95K	Hold	1	–	–	﹤0.01%	1462
2013 Q3	$3.13K	Buy	+1	New	+$7.5K	﹤0.01%	1484

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

SGAM

Smith Group Asset Management Dallas, Texas $2.46B AUM 57.16% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SAIG

Semper Augustus Investments Group Highlands Ranch, Colorado $837M AUM 42.35% 1-Year Est. Return

Schroder Investment Management Group's FRTX Position: Q4 2014 in Review

Schroder Investment Management Group sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2014, closing a stake of 1 share — an estimated $2.8K sold.

Schroder Investment Management Group first reported a position in FRTX in Q3 2013 and held it in 5 quarters. The position peaked at $3.23K in Q1 2014. 64 funds tracked by Wall St. Rank hold FRTX as of Q4 2014.

Schroder Investment Management Group reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
Schroder Investment Management Group sold 1 Fresh Tracks Therapeutics, Inc. Common Stock share in Q4 2014, an estimated $2.8K.
Schroder Investment Management Group first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2013 and held it in 5 quarters.
Schroder Investment Management Group's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $3.23K in Q1 2014.
64 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2014.

Based on Schroder Investment Management Group's 13F filing for Q4 2014, filed 17 Feb 2015.